EuroPCR2021 kicked off productive discussions on CTO strategy on May 18th, APT is honored to participate in this world-leading course in interventional cardiovascular medicine.
A clinical case is presented with a bilateral distal radial approach and successful treatment of chronic coronary occlusion through APT thin-walled 7F introducers
APT Medical hosted its first Latin America focused webinar: New Insights into Cardiovascular Latin America Perspective on March 26th 2021.
APT Medical’s opening online symposium in 2021, CollecTiOn: Sharing Expertise from West through East, was successfully held on February 4th, 2021.
January 7, 2021 –APT Medical (SHSE: 688617) successfully listed on the Science and Technology Innovation Board (the STAR Board) of the Shanghai Stock Exchange today.